Home › Funds › Two Sigma Investments › SPRO
Two Sigma Investments position in SPRO
SPERO THERAPEUTICS INC · Health Care
Latest position (Q2 2026)382.81K sh
Reported value held$846.02K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 78.91K | $686.00K | New |
| Q2 2022 | 437.28K | $324.00K | Add |
| Q4 2022 | 39.80K | $68.84K | New |
| Q1 2023 | 32.10K | $46.55K | Reduce |
| Q2 2023 | 84.53K | $122.58K | Add |
| Q3 2023 | 17.02K | $20.60K | Reduce |
| Q3 2025 | 49.40K | $92.87K | New |
| Q4 2025 | 372.57K | $868.09K | Add |
| Q1 2026 | 885.63K | $2.07M | Add |
| Q2 2026 | 382.81K | $846.02K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SPRO
- Vanguard Group 2.08M sh · $4.85M · Q4 2025
- Renaissance Technologies 947.90K sh · $2.09M · Q2 2026
- BlackRock Inc 594.40K sh · $1.31M · Q2 2026
- Geode Capital Management 566.33K sh · $1.25M · Q2 2026
- Arrowstreet Capital 332.97K sh · $735.86K · Q2 2026
- Goldman Sachs Group 256.99K sh · $567.94K · Q2 2026
- UBS Group AG 139.68K sh · $308.69K · Q2 2026
- Northern Trust Corp 108.27K sh · $239.29K · Q2 2026
- Point72 Asset Management 104.38K sh · $230.67K · Q2 2026
- Citadel Advisors 65.60K sh · $144.98K · Q2 2026
- Invesco Ltd 64.25K sh · $141.98K · Q2 2026